Sail Biomedicines
Programmable circular "Endless RNA" (eRNA) medicines with AI, from Flagship Pioneering
Biotech
📍 Cambridge, MA
Founded 2023
Current Valuation
Private
PRIVATE
Sail Biomedicines is a Cambridge, MA RNA-medicines company formed in October 2023 by Flagship Pioneering through the merger of Laronde (Endless RNA / circular RNA) and Senda Biosciences (programmable delivery). Led by CEO Guillaume Pfefer with John Mendlein as executive chairman, Sail pairs a programmable circular-RNA platform with AI-guided design and novel delivery to build durable RNA therapeutics and vaccines.
Company Profile
Growth
Flagship-funded platform company; pipeline building
Fundraising Status
private
Founders & Key People
Flagship Pioneering
Investors
Flagship Pioneering
Products
- Endless RNA (eRNA) circular RNA platform
- Programmable RNA medicines
- Lipid / anellovirus delivery (from Senda)
Competitors
Orbital Therapeutics · Orna Therapeutics · Therna Biosciences
BiotechRNA TherapeuticsCircular RNATechBioFlagship Pioneering
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.